NCT06002243

Brief Summary

The Non-Expert Acquisition and Remote Expert Review of Screening echocardiography images from Child health and AnteNatal clinics (NEARER SCAN) study is a co-designed, implementation research project that will improve equitable access to culturally safe, best quality care for Rheumatic Heart Disease (RHD) in high-burden Aboriginal and Torres Strait Islander communities in Australia, and in Timor-Leste. The research addresses an area of unmet need, using novel technologies and embedding them in health practice, to enhance and accelerate diagnosis of RHD outside acute health settings and improve outcomes. The study will be conducted in partnership with community leaders and local partners.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

March 18, 2024

Status Verified

March 1, 2024

Enrollment Period

1.2 years

First QC Date

June 13, 2023

Last Update Submit

March 15, 2024

Conditions

Keywords

EchocardiographyTask-sharingAboriginal and Torres Strait Islander PeoplesPregnancyChildrenFirst Nation Peoples

Outcome Measures

Primary Outcomes (1)

  • Change in proportion receiving secondary antibiotic prophylaxis

    The change in proportion of the at-risk population receiving secondary antibiotic prophylaxis at the end of the study as compared to baseline

    18 months from commencement of study

Secondary Outcomes (7)

  • Full echocardiogram following screening echocardiogram

    3 months from screening echocardiogram

  • Proportion of people diagnosed with RHD who are retained in care

    18 months from commencement of study

  • Secondary antibiotic prophylaxis prescription and adherence

    12 months from time of diagnosis or at end of the study (which ever is longer).

  • Maternal morbidity and mortality outcomes

    Within 6 weeks of the individual's post-partum period

  • Prevalence of rheumatic heart disease within the screened population

    18 months from commencement of study

  • +2 more secondary outcomes

Study Arms (1)

Intervention

EXPERIMENTAL

Participant receiving echocardiography screening.

Diagnostic Test: SPLASH echocardiography screening

Interventions

Screening echocardiogram performed by a briefly trained health worker with images reviewed off site by an expert cardiologist or cardiac sonographer to determine screening outcome. Screening outcome may include: screen positive, screen negative or uninterpretable images.

Intervention

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Any child between the age of 5 - 20 years old living in the participating community
  • Pregnant women at high risk for RHD undergoing antenatal appointments or a hospital admission will be invited to participate. High risk for RHD will be defined as being from an area where RHD all-age prevalence is \>1/1000 RHD or acute rheumatic fever incidence \>30/100,000 per year in 5-14-year-olds. For practical purposes, this means Aboriginal women living in urban, rural or remote communities in northern Australia, or immigrants from high-risk settings.
  • Any child between the age of 5-20 years old and any pregnant woman.

You may not qualify if:

  • Women who are unable to consent due to physical, mental, or intellectual disability will be excluded. Women and children with known existing cardiac disease will NOT be excluded since evaluation of severity and change in severity during pregnancy will be tracked, and data will inform the calculation of prevalence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Jones B, Marangou J, Yan J, Ralph A, Mitchell A, Kaethner A, Remenyi B, Wade V, Katzenellenbogen JM, Monteiro AF, Cannon JW, Howard NJ, Gilles M, Haynes E, Seixas H, Maurays J, Neave J, Pears C, Engelman D, Canuto K, Steer A, Unger H, Bailey M, Tanesi M, Amaral S, Neto H, Stewart M, Burgess P, Brown A, Currie BJ, Hillis G, Morris P, Simon D, Wheaton G, Williamson J, de Dassel J, Slota-Kan S, Carapetis J, English M, Nagraj S, Francis JR. NEARER SCAN (LENO BESIK) evaluation of a task-sharing echocardiographic active case finding programme for rheumatic heart disease in Australia and Timor-Leste: protocol for a hybrid type II effectiveness-implementation study. BMJ Open. 2024 Oct 18;14(10):e083467. doi: 10.1136/bmjopen-2023-083467.

MeSH Terms

Conditions

Rheumatic Heart Disease

Condition Hierarchy (Ancestors)

Rheumatic FeverStreptococcal InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsHeart DiseasesCardiovascular Diseases

Study Officials

  • Joshua R Francis, MBBS

    Menzies School of Health Research

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joshua R Francis, MBBS

CONTACT

James A Marangou, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Fellow

Study Record Dates

First Submitted

June 13, 2023

First Posted

August 21, 2023

Study Start

April 1, 2024

Primary Completion

June 1, 2025

Study Completion

December 1, 2025

Last Updated

March 18, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share